Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Quidelortho Corp (QDEL)

Quidelortho Corp (QDEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
QuidelOrtho: Q3 Earnings Snapshot

QuidelOrtho: Q3 Earnings Snapshot

QDEL : 40.02 (-2.72%)
Why QuidelOrtho Stock Blasted 10% Higher Today

The healthcare company has significant and untapped earnings potential, asserts one pundit.

QDEL : 40.02 (-2.72%)
QuidelOrtho: Q2 Earnings Snapshot

QuidelOrtho: Q2 Earnings Snapshot

QDEL : 40.02 (-2.72%)
Why QuidelOrtho Stock Is Crashing Today

The in vitro diagnostics company had a lot of bad news in its Q4 update.

QDEL : 40.02 (-2.72%)
Powerful Lyme Disease Awareness PSA Featuring Christopher Meloni Illuminates Times Square

/PRNewswire/ -- In an inspiring and emotional display of solidarity for Lyme disease awareness, a striking public service announcement (PSA) has taken center...

QDEL : 40.02 (-2.72%)
QuidelOrtho Reports First Quarter 2023 Financial Results

QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and...

QDEL : 40.02 (-2.72%)
Why QuidelOrtho Stock Popped by 5% on Friday

It looks like the company's first quarter is going to please investors greatly.

QDEL : 40.02 (-2.72%)
QuidelOrtho Reports Preliminary Revenue Results for the First Quarter 2023

QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and...

QDEL : 40.02 (-2.72%)
QuidelOrtho Announces the Formation of the International QuidelOrtho Women’s Leadership Network (QWLN)

QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine,...

QDEL : 40.02 (-2.72%)
QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA

QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine,...

QDEL : 40.02 (-2.72%)

Barchart Exclusives

1 Dividend Stock to Grab Now for Long-Term Upside
This article highlights a dividend-paying stock that offers solid long-term upside potential. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar